This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Health Capital Partners Announces Closing Of Investment Fund With Anchor Investment From ORIX USA Asset Management

New Health Capital Partners, LLC (“ New Health” or “ NHCP”) announced today that it has closed on New Health Capital Partners Fund I LP, a private equity vehicle focused on investing throughout the capital structure of life sciences companies, including senior secured loans, royalty monetizations, control equity investments and other structured financings. The New York-based firm received an initial capital commitment of $150,000,000 from ORIX USA Asset Management (“ OAM”), a global asset management firm.

NHCP seeks to create highly customized investment structures which provide significantly more flexibility to companies than capital traditionally available via the public markets, private equity or pure royalty monetization firms. New Health is uniquely able to provide capital to a broad spectrum of commercial-stage specialty pharmaceutical, medical devices, diagnostics and technology tools companies.

The founders of NHCP, Richard Baxter and Aron Dantzig, have worked together for the past seven years, deploying in excess of $1 billion. NHCP’s principals have completed one transaction since the firm’s launch and are reviewing a number of additional investment opportunities as the firm rapidly broadens its transaction pipeline.

“We are excited to announce our launch with the substantial capital commitment from ORIX USA Asset Management,” said Richard Baxter, “and look forward to continuing to deploy innovative forms of capital into the healthcare industry.”

Michael Blum, President and CEO of ORIX USA Asset Management, commented, “We are very excited about our relationship with NHCP. Partnering with Aron and Rich and their team gives ORIX USA Asset Management a unique opportunity to invest in the healthcare and life sciences sectors and further highlights our commitment to the global asset management industry.”

“Access to cost-efficient capital continues be a challenge for many life science-focused companies,” added Aron Dantzig, “and we are seeing consistently increasing demand for our type of non-traditional capital.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs